Nat

Procleix Plasmodium Assay (CE Marked)

Ref. GRF-PROCLEIX-PLASMODIUM-ASSAY

Single-tube, highly sensitive detection of the 18S ribosomal RNA of the Plasmodium parasite in whole blood specimens.

Tests per card —
Packaging 1000 or 5000 tests
Contact us for product availability and technical details.

About the Product

Single-tube, highly sensitive detection of the 18S ribosomal RNA of the Plasmodium parasite in whole blood specimens.

The Procleix Plasmodium assay is CE marked. This assay is not available for commercial sale in the US.

References: Procleix Plasmodium assay package insert, GDSS-IFU-000069-EN v. 1.0

Technical Characteristics

Regulatory status CE Marked
Assay chemistry Qualitative, transcription-mediated amplification (TMA)
Indication Whole blood and blood component screening
Collection tube Whole blood from K2EDTA, K3EDTA, sodium citrate, and citrate phosphate dextrose adenine solution (CPDA) anti-coagulated samples
Pool sizes ID-NAT, 4, 8, 16
Detected pathogen Plasmodium parasite (species: P. falciparum, P. knowlesi, P. malariae, P. ovale, and P. vivax)
Specificity in fresh whole blood specimens from blood donors - Individual donations # of samples: 12,812; IC Invalids: 12; True Negative: 12,799; False Positive: 1; Specificity (%): 99.99; 95% confidence interval: 99.96 - 100
Specificity in fresh whole blood specimens from blood donors - 16-sample pool # of samples: 283; IC Invalids: 0; True Negative: 283; False Positive: 0; Specificity (%): 100; 95% confidence interval: 98.71 - 100
Analytical sensitivity, in vitro transcript (copies/mL) - P. falciparum 50% Detection Probability (95% fiducial limits): 3.35 (2.63 - 4.09); 95% Detection Probability (95% fiducial limits): 11.37 (8.88 - 16.19)
Analytical sensitivity, in vitro transcript (copies/mL) - P. knowlesi 50% Detection Probability (95% fiducial limits): 3.00 (2.39 - 3.63); 95% Detection Probability (95% fiducial limits): 9.08 (7.21 - 12.58)
Analytical sensitivity, in vitro transcript (copies/mL) - P. malariae 50% Detection Probability (95% fiducial limits): 2.96 (2.38 - 3.57); 95% Detection Probability (95% fiducial limits): 8.47 (6.80 - 11.45)
Analytical sensitivity, in vitro transcript (copies/mL) - P. ovale 50% Detection Probability (95% fiducial limits): 2.14 (1.51 - 2.76); 95% Detection Probability (95% fiducial limits): 11.16 (8.15 - 18.01)
Analytical sensitivity, in vitro transcript (copies/mL) - P. vivax 50% Detection Probability (95% fiducial limits): 2.97 (2.27 - 3.70); 95% Detection Probability (95% fiducial limits): 11.89 (9.04 - 17.74)
Analytical sensitivity, infected RBCs (cells/mL) - P. falciparum 50% Detection Probability (95% fiducial limits): 0.82 (0.61 - 1.00); 95% Detection Probability (95% fiducial limits): 3.50 (2.85 - 4.62)
Analytical sensitivity, infected RBCs (cells/mL) - P. knowlesi 50% Detection Probability (95% fiducial limits): 0.66 (0.50 - 0.79); 95% Detection Probability (95% fiducial limits): 2.10 (1.72 - 2.87)
Analytical sensitivity, infected RBCs (cells/mL) - P. malariae 50% Detection Probability (95% fiducial limits): 0.38 (0.21 - 0.54); 95% Detection Probability (95% fiducial limits): 2.39 (1.85 - 3.59)
Analytical sensitivity, infected RBCs (cells/mL) - P. ovale 50% Detection Probability (95% fiducial limits): 1.65 (1.33 - 1.96); 95% Detection Probability (95% fiducial limits): 6.82 (5.63 - 8.75)
Analytical sensitivity, infected RBCs (cells/mL) - P. vivax 50% Detection Probability (95% fiducial limits): 0.61 (0.08 - 1.08); 95% Detection Probability (95% fiducial limits): 2.85 (1.66 - 16.75)

Technical Information

No technical information available for this product.

Compatibility

Platform: Procleix Panther system

Packaging

1000 or 5000 tests